At Fresenius Kabi we care for the life of patients worldwide. To fulfill our commitment to benefit critically and chronically ill patients, collaborating with Healthcare Professionals, hospitals and patient organisations is essential. These partnerships are not only required to develop products that best meet clinical needs. Healthcare Professionals are provided with the necessary expertise and education to be able to safely and effectively use our drugs and medical devices. In supporting medical research and education Fresenius Kabi contributes to patient safety and increased access to new technologies and services.
We expect transparency, accountability and high ethical standards from ourselves – and our stakeholders expect the same from us. Their trust is rewarded by acting with utmost integrity and responsibility. We believe that transparency is key to safeguard the integrity of these partnerships to the public and remain trusted.
Being member of various industry associations in the countries we are operating in, we have committed ourselves to disclose certain value transfers to Healthcare Professionals, Healthcare Organizations and selected patient care organizations in these countries.
In each such interaction, we respect the obligation of Healthcare Professionals to make independent treatment decisions.
Please see below for the Fresenius Health Care Group Pension Scheme, Statement of Investment Principles - September 2020
Please see below for the Fresenius Kabi Enagagement Policy Implementation Statement 2020
HCP / HCO Disclosure Values 2019
Please see below for the HCP / HCP Disclosure Values for 2019
Fresenius Kabi Limited and Calea UK Limited 2020 Patient Organisations Disclosure Report
We believe that being transparent about our support for patient groups helps to build trust with our stakeholders. During 2020 we provide support to numerous patient organisations. To read the full report click here
Fresenius Kabi Limited and Calea UK Limited Methodological Notes for Reporting 2020
We welcome any questions or remarks at firstname.lastname@example.org.